

Cover Story
Clinical
In an industry that set its sights on reshaping cancer detection, GRAIL Inc. had the appearance of a pioneer.
In Brief


Clinical Roundup


Drugs & Targets


Trending Stories
- Mikaela Naylon Give Kids a Chance Act nixed by Senate
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- Otis Brawley looks back on a year of great science and greater challenges
- Twitter star Vinay Prasad retires @VinayPrasadMD
- AI will determine Medicare prior authorizations in six states under new pilot program
- GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation














